Viking Therapeutics announced its new Chief Commercial Officer, Neil Aubuchon, on Jan. 7, 2026. Viking is a clinical-stage biopharmaceutical company specializing in development of novel therapies for metabolic and endocrine disorders. “Today, novel metabolic therapeutics are revolutionizing healthcare, particularly as life-changing treatments for people with obesity,” Aubuchon said. “I am excited to join the team and continue Viking’s work to engage with stakeholders i...